Other Events ·
At its 2026 Annual Meeting of Stockholders held on July 9, 2026, Cingulate Inc. stockholders approved Amendment No. 3…
CINGCingulate Inc.
At its 2026 Annual Meeting of Stockholders held on July 9, 2026, Cingulate Inc. stockholders approved Amendment No. 3 to the 2021 Omnibus Equity Incentive Plan, increasing authorized shares by 625,000 to a total of 2,221,126. The Board of Directors reduced its size to five members and appointed CEO Shane Schaffer as chairman, with Jeff Hargroves serving as lead independent director. Jeff Hargroves was also elected as a Class II director. Additionally, stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Cingulate Inc. is a technology company focused on diagnostic solutions.